HYBRID CONCEPTS INTERNATIONAL Trademark

Trademark Overview


On Friday, December 10, 2021, a trademark application was filed for HYBRID CONCEPTS INTERNATIONAL with the United States Patent and Trademark Office. The USPTO has given the HYBRID CONCEPTS INTERNATIONAL trademark a serial number of 97167024. The federal status of this trademark filing is REGISTERED as of Tuesday, March 28, 2023. This trademark is owned by HYBRID CONCEPTS INTERNATIONAL, LLC. The HYBRID CONCEPTS INTERNATIONAL trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Financial consulting services, namely, advising others regarding intellectual property investments; Investment consultation in the fields of product, technical, regulatory, preclinical, clinical, and commercial diligence for innovative potential or investigational medical products

Assistance, advisory services and consultancy with regard to business planning; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting services; Business consulting services in the field of potential medical cures including cell and gene therapies; Business consultation in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, regulatory affairs including preclinical, clinical and commercial stage, pharmaceutical preclinical and clinical research, development, chemistry, manufacturing and controls, and quality assurance/quality control; Business consulting services, namely, providing assistan...

Consulting services in the field of health; Consulting services to health care providers in the field of treating life-changing or life-threatening diseases

Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research information in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, regulatory affairs including preclinical, clinical and commercial stage, pharmaceutical preclinical and clinical research, development, manufacturing/CMC and quality assurance/quality control; Providing information about medical and scientific research; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific resea...
hybrid concepts international

General Information


Serial Number97167024
Word MarkHYBRID CONCEPTS INTERNATIONAL
Filing DateFriday, December 10, 2021
Status700 - REGISTERED
Status DateTuesday, March 28, 2023
Registration Number7009804
Registration DateTuesday, March 28, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 10, 2023

Trademark Statements


Description of MarkThe mark consists of the words HYBRID CONCEPTS above the word INTERNATIONAL, the letter Os being atoms or cells within a molecular or cellular design.
Goods and ServicesFinancial consulting services, namely, advising others regarding intellectual property investments; Investment consultation in the fields of product, technical, regulatory, preclinical, clinical, and commercial diligence for innovative potential or investigational medical products
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesAssistance, advisory services and consultancy with regard to business planning; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting services; Business consulting services in the field of potential medical cures including cell and gene therapies; Business consultation in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, regulatory affairs including preclinical, clinical and commercial stage, pharmaceutical preclinical and clinical research, development, chemistry, manufacturing and controls, and quality assurance/quality control; Business consulting services, namely, providing assistance in development of business strategies and creative ideation; Business management consulting and advisory services; Business support services, namely, business consulting to freelancers, start-ups, existing businesses and non-profit organizations; Consultancy and advisory services in the field of business strategy; Consulting services in the field of medical product approval for commercial purposes; International business consulting services relating to USA and outside of USA product, clinical and commercial development of investigational or approved medical products; New business venture development and formation consulting services; Promoting the exchange of information and resources within the scientific research communities to achieve advances in the field of 21st century transformational science; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Providing independent review of clinical trials for business purposes; Promoting technical and scientific investigation, research and experimentation in the field of scientific discovery through support of educational institutions and scientific organizations
Goods and ServicesConsulting services in the field of health; Consulting services to health care providers in the field of treating life-changing or life-threatening diseases
Disclaimer with Predetermined Text"INTERNATIONAL"
Goods and ServicesConsulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research information in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, regulatory affairs including preclinical, clinical and commercial stage, pharmaceutical preclinical and clinical research, development, manufacturing/CMC and quality assurance/quality control; Providing information about medical and scientific research; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific and technological services, namely, scientific research in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; Scientific research consulting in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; Scientific research and development; Technological planning and consulting services in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific consulting and research services relating to foods and dietary supplements; Scientific research consulting in the field of cosmetics

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, December 15, 2021
Primary Code035
First Use Anywhere DateFriday, June 30, 2017
First Use In Commerce DateFriday, June 30, 2017

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, December 15, 2021
Primary Code036
First Use Anywhere DateFriday, June 30, 2017
First Use In Commerce DateFriday, June 30, 2017

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 15, 2021
Primary Code042
First Use Anywhere DateFriday, June 30, 2017
First Use In Commerce DateFriday, June 30, 2017

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 15, 2021
Primary Code044
First Use Anywhere DateThursday, August 31, 2017
First Use In Commerce DateThursday, August 31, 2017

Trademark Owner History


Party NameHYBRID CONCEPTS INTERNATIONAL, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressGRAND ISLAND, NY 14072

Party NameHYBRID CONCEPTS INTERNATIONAL, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressGRAND ISLAND, NY 14072

Party NameHYBRID CONCEPTS INTERNATIONAL, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressGRAND ISLAND, NY 14072

Trademark Events


Event DateEvent Description
Tuesday, March 28, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 28, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, January 10, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 10, 2023PUBLISHED FOR OPPOSITION
Wednesday, December 21, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 2, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 1, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 30, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 30, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 17, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 17, 2022NON-FINAL ACTION E-MAILED
Thursday, November 17, 2022NON-FINAL ACTION WRITTEN
Friday, November 11, 2022PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, October 4, 2022WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, September 20, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 20, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, September 20, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 20, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, September 20, 2022EXAMINERS AMENDMENT -WRITTEN
Monday, September 19, 2022ASSIGNED TO EXAMINER
Thursday, December 16, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, December 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 14, 2021NEW APPLICATION ENTERED